These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16962152)

  • 1. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.
    Smith DM; Strain MC; Frost SD; Pillai SK; Wong JK; Wrin T; Liu Y; Petropolous CJ; Daar ES; Little SJ; Richman DD
    Virology; 2006 Nov; 355(1):1-5. PubMed ID: 16962152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.
    Wagner GA; Landais E; Caballero G; Phung P; Kosakovsky Pond SL; Poignard P; Richman DD; Little SJ; Smith DM
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia.
    Günthard HF; Huber M; Kuster H; Shah C; Schüpbach J; Trkola A; Böni J
    Clin Infect Dis; 2009 Jun; 48(11):e117-20. PubMed ID: 19382874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection.
    Basu D; Kraft CS; Murphy MK; Campbell PJ; Yu T; Hraber PT; Irene C; Pinter A; Chomba E; Mulenga J; Kilembe W; Allen SA; Derdeyn CA; Hunter E
    Retrovirology; 2012 Sep; 9():76. PubMed ID: 22995123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research. 'Superinfected' have more potent antibody response to HIV.
    AIDS Policy Law; 2012 May; 27(6):3. PubMed ID: 22655314
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan Women.
    Ronen K; Dingens AS; Graham SM; Jaoko W; Mandaliya K; McClelland RS; Overbaugh J
    EBioMedicine; 2017 Apr; 18():216-224. PubMed ID: 28427948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.
    Forthal DN; Landucci G; Chohan B; Richardson BA; McClelland RS; Jaoko W; Blish C; Overbaugh J
    J Acquir Immune Defic Syndr; 2013 May; 63(1):31-3. PubMed ID: 23344546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.
    Serwanga J; Ssemwanga D; Muganga M; Nakiboneka R; Nakubulwa S; Kiwuwa-Muyingo S; Morris L; Redd AD; Quinn TC; Kaleebu P;
    Vaccine; 2018 Jan; 36(4):578-586. PubMed ID: 29274699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
    Björling E; Scarlatti G; von Gegerfelt A; Albert J; Biberfeld G; Chiodi F; Norrby E; Fenyö EM
    Virology; 1993 Mar; 193(1):528-30. PubMed ID: 8438591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV superinfection in women may boost immune response.
    Rose S
    Expert Rev Anti Infect Ther; 2012 May; 10(5):525. PubMed ID: 22702314
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
    Ssemwanga D; Doria-Rose NA; Redd AD; Shiakolas AR; Longosz AF; Nsubuga RN; Mayanja BN; Asiki G; Seeley J; Kamali A; Ransier A; Darko S; Walker MP; Bruno D; Martens C; Douek D; Porcella SF; Quinn TC; Mascola JR; Kaleebu P
    J Infect Dis; 2018 Apr; 217(10):1530-1534. PubMed ID: 29579256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.
    Cortez V; Odem-Davis K; McClelland RS; Jaoko W; Overbaugh J
    PLoS Pathog; 2012; 8(3):e1002611. PubMed ID: 22479183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neutralizing antibodies in HIV infection.
    Humbert M; Dietrich U
    AIDS Rev; 2006; 8(2):51-9. PubMed ID: 16848273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect?
    Jülg B; Goebel FD
    Infection; 2005 Oct; 33(5-6):405-7. PubMed ID: 16258878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1.
    Fernández Larrosa PN; Ceballos A; Andreani G; Marquina S; Martínez Peralta L; Rabinovich RD
    Arch Virol; 2006 Apr; 151(4):651-62. PubMed ID: 16362643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfection.
    Basu D; Xiao P; Ende Z; Bere A; Britt WJ; Mulenga J; Kilembe W; Allen SA; Derdeyn CA; Hunter E
    Virology; 2014 Aug; 462-463():295-8. PubMed ID: 25004405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.
    Blish CA; Dogan OC; Derby NR; Nguyen MA; Chohan B; Richardson BA; Overbaugh J
    J Virol; 2008 Dec; 82(24):12094-103. PubMed ID: 18842728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.
    Chaillon A; Wagner GA; Hepler NL; Little SJ; Kosakovsky Pond SL; Caballero G; Pacold ME; Phung P; Wrin T; Richman DD; Wertheim JO; Smith DM
    J Virol; 2013 Dec; 87(23):12737-44. PubMed ID: 24049166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
    AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level serum neutralizing antibody against HIV-1 in Chinese long-term non-progressors.
    Wang Q; Shang H; Han X; Zhang Z; Jiang Y; Wang Y; Dai D; Diao Y
    Microbiol Immunol; 2008 Apr; 52(4):209-15. PubMed ID: 18426395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.